chr17-81510578-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001614.5(ACTG1):​c.*112C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00236 in 1,378,522 control chromosomes in the GnomAD database, including 70 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0012 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0025 ( 65 hom. )

Consequence

ACTG1
NM_001614.5 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.332

Publications

0 publications found
Variant links:
Genes affected
ACTG1 (HGNC:144): (actin gamma 1) Actins are highly conserved proteins that are involved in various types of cell motility and in maintenance of the cytoskeleton. Three main groups of actin isoforms have been identified in vertebrate animals: alpha, beta, and gamma. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins co-exist in most cell types as components of the cytoskeleton and as mediators of internal cell motility. Actin gamma 1, encoded by this gene, is a cytoplasmic actin found in all cell types. Mutations in this gene are associated with DFNA20/26, a subtype of autosomal dominant non-syndromic sensorineural progressive hearing loss and also with Baraitser-Winter syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
ACTG1 Gene-Disease associations (from GenCC):
  • Baraitser-winter syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss 20
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Baraitser-Winter cerebrofrontofacial syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 17-81510578-G-A is Benign according to our data. Variant chr17-81510578-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1198354.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00122 (186/152324) while in subpopulation SAS AF = 0.0329 (159/4830). AF 95% confidence interval is 0.0287. There are 5 homozygotes in GnomAd4. There are 132 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 186 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACTG1NM_001614.5 linkc.*112C>T 3_prime_UTR_variant Exon 6 of 6 ENST00000573283.7 NP_001605.1 P63261
ACTG1NR_037688.3 linkn.1312C>T non_coding_transcript_exon_variant Exon 6 of 7
ACTG1NM_001199954.3 linkc.*112C>T 3_prime_UTR_variant Exon 6 of 6 NP_001186883.1 P63261

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACTG1ENST00000573283.7 linkc.*112C>T 3_prime_UTR_variant Exon 6 of 6 5 NM_001614.5 ENSP00000458435.1 P63261

Frequencies

GnomAD3 genomes
AF:
0.00122
AC:
186
AN:
152206
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0329
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.00400
AC:
942
AN:
235458
AF XY:
0.00542
show subpopulations
Gnomad AFR exome
AF:
0.000146
Gnomad AMR exome
AF:
0.000181
Gnomad ASJ exome
AF:
0.00247
Gnomad EAS exome
AF:
0.000459
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000487
Gnomad OTH exome
AF:
0.00275
GnomAD4 exome
AF:
0.00250
AC:
3068
AN:
1226198
Hom.:
65
Cov.:
17
AF XY:
0.00349
AC XY:
2164
AN XY:
620856
show subpopulations
African (AFR)
AF:
0.000175
AC:
5
AN:
28638
American (AMR)
AF:
0.000162
AC:
7
AN:
43110
Ashkenazi Jewish (ASJ)
AF:
0.00308
AC:
76
AN:
24646
East Asian (EAS)
AF:
0.000130
AC:
5
AN:
38484
South Asian (SAS)
AF:
0.0300
AC:
2437
AN:
81100
European-Finnish (FIN)
AF:
0.0000192
AC:
1
AN:
52012
Middle Eastern (MID)
AF:
0.00699
AC:
26
AN:
3722
European-Non Finnish (NFE)
AF:
0.000408
AC:
368
AN:
902110
Other (OTH)
AF:
0.00273
AC:
143
AN:
52376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
210
421
631
842
1052
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00122
AC:
186
AN:
152324
Hom.:
5
Cov.:
32
AF XY:
0.00177
AC XY:
132
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41564
American (AMR)
AF:
0.000131
AC:
2
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.0329
AC:
159
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68034
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000983
Hom.:
0
Bravo
AF:
0.000404
Asia WGS
AF:
0.00606
AC:
21
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 28, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
8.0
DANN
Benign
0.91
PhyloP100
0.33
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs368494254; hg19: chr17-79477604; API